Infographic: PDX models and precision oncology

We recently shared preclinical data on seribantumab in NRG1 fusion PDX models at EORTC-NCI-AACR 2020. Here’s a closer look at what PDX models are, and why they’re such important tools for developing precision medicines for cancer:


Like This Content?


Go even deeper in “NRG1 fusions – a (PDX) model challenge” by Shawn Leland, our Founder and CEO.

Read the Full Article